MCMedicalCodingSoftware
J1953

J1953: Injection, levetiracetam, 10 mg

HCPCSTerminatedBETOS O1E

J1953 is a HCPCS Level II code for injection, levetiracetam, 10 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on September 30, 2026 and is not valid on new claims.

This code has been terminated

CMS terminated J1953 on September 30, 2026. It stays in the file as history: a claim you are auditing from before that date may legitimately carry it, but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q4-Oct. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits: units per day

The most units of J1953 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
300 units
MAI 3: Date of Service Edit: Clinical · Prescribing Information
outpatient
300 units
MAI 3: Date of Service Edit: Clinical · Prescribing Information
DME supplier
0, never payable
MAI 3: Date of Service Edit: Clinical · CMS Policy

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute, no documentation overrides it. CMS MUE 2026Q4.

The CMS record for J1953

Long descriptor
Injection, levetiracetam, 10 mg

The official wording. This is what the code means.

Short descriptor
Levetiracetam injection

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2009

When CMS introduced the code.

Terminated
September 30, 2026

When CMS retired it.

BETOS
O1E

Berenson-Eggers Type of Service: CMS's own analytic grouping.

Pricing indicator
51: Other

Drugs.

Codes adjacent to J1953

HCPCS has no hierarchy: related items simply sit next to each other in the numbering. If J1953 is not quite right, the correct code is very often within a few positions of it.

  • J1943Injection, aripiprazole lauroxil, (aristada initio), 1 mg
  • J1944Injection, aripiprazole lauroxil, (aristada), 1 mg
  • J1945Injection, lepirudin, 50 mgterminated
  • J1946Injection, furosemide (lasix onyu), 1 mg
  • J1947Injection, furosemide (furoscix), 1 mg
  • J1950Injection, leuprolide acetate (for depot suspension), per 3.75 mg
  • J1951Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg
  • J1952Leuprolide injectable, camcevi, 1 mg
  • J1954Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg
  • J1955Injection, levocarnitine, per 1 gm
  • J1956Injection, levofloxacin, 250 mg
  • J1957Injection, levetiracetam, 5 mg
  • J1958Injection, levetiracetam in sodium chloride, 5 mg
  • J1960Injection, levorphanol tartrate, up to 2 mg
  • J1961Injection, lenacapavir (only for use as hiv treatment), 1 mg
  • J1980Injection, hyoscyamine sulfate, up to 0.25 mg
HCPCS Level II2026Q4-Oct· effective October 1, 2026